Pertuzumab (P) + trastuzumab (H) + chemotherapy (CT) for HER2-positive metastatic gastric or gastro-oesophageal junction cancer (mGC/GEJC): Final analysis of a Phase III study (JACOB)

Josep Tabernero, Paulo M. Hoff, Lin Shen, Atsushi Ohtsu, Manish A. Shah, Kuo‐Sheng Cheng, Changhua Song, Haiyan Wu, Jennifer Eng‐Wong, Y-K. Kang

Annals of Oncology · 2017 · 58 citations · 0 references

DOIFull text

Open access

Concepts